Liquidia Technologies in Durham gets $20 million in venture capital, b3bio, a biotech startup in Research Triangle Park, teams up with pharma giant Roche in a big way and Prolacria, Inspire Pharmaceuticals’ dry eye drug, fails yet another late-stage trial. Read more…
SITT bloggers and journalists share observations, ideas and opinions about the Research Triangle Park region. Contributors include Ross Maloney, Sabine Volmer, DeLene Beeland and Bora Zivkovic, as well as members of the Science Communicators of North Carolina (SCONC). Our intended audience members are researchers, scientists, students, businesses, residents and the otherwise science-curious of our region.
Science in the Triangle is a community service provided by the Research Triangle Park and Blue Pane Studio, in partnership with Museum of Life + Science.
© 2008-2009, All Rights Reserved.
